According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -$3.10. In 2022 the company made an earnings per share (EPS) of -$3.33 an increase over its 2021 EPS that were of -$3.66.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.10 | -6.91% |
2022 | -$3.33 | -9.02% |
2021 | -$3.66 | 68.93% |
2020 | -$2.17 | 81.17% |
2019 | -$1.20 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Pfizer PFE | $1.86 | -160.00% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $3.50 | -212.93% | ๐ฌ๐ง UK |
Sarepta Therapeutics
SRPT | -$7.83 | 152.58% | ๐บ๐ธ USA |
PTC Therapeutics
PTCT | -$8.65 | 179.03% | ๐บ๐ธ USA |
Fate Therapeutics
FATE | -$2.17 | -30.00% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | -$9.78 | 215.40% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | $1.10 | -135.48% | ๐บ๐ธ USA |